Literature DB >> 33291732

Clinical Evaluation of Acetaminophen-Galgeuntang Interaction Based on Population Approaches.

Quyen Thi Tran1, So Jung Park2, Hyun-Moon Back3, Lien Thi Ngo1, Duc Tuan Cao4, Hung Van Nguyen5, Sangkeun Jung6, Jung-Woo Chae1, Yang Chun Park2, Hwi-Yeol Yun1.   

Abstract

Galgeuntang (GGT), a traditional herbal medicine, is widely co-administered with acetaminophen (AAP) for treatment of the common cold, but this combination has not been the subject of investigation. Therefore, we investigated the herb-drug interaction between GGT and AAP by population pharmacokinetics (PKs) modeling and simulation studies. To quantify PK parameters and identify drug interactions, an open label, three-treatment, three-period, one-sequence (AAP alone, GGT alone, and AAP and GGT in combination) clinical trial involving 12 male healthy volunteers was conducted. Ephedrine (EPD), the only GGT component detected, was identified using a one-compartment model. The PKs of AAP were described well by a one-compartment model and exhibited two-phase absorption (rapid followed by slow) and first-order elimination. The model showed that EPD significantly influenced the PKs of AAP. The simulation results showed that at an AAP dose of 1000 mg × 4 times daily, the area under the concentration versus time curve of AAP increased by 16.4% in the presence of GGT compared to AAP only. In conclusion, the PKs of AAP were affected by co-administration of GGT. Therefore, when AAP is combined with GGT, adverse effects related to overdose of AAP could be induced possibly.

Entities:  

Keywords:  Galgeuntang; acetaminophen; drug interaction; population pharmacokinetics

Year:  2020        PMID: 33291732      PMCID: PMC7761965          DOI: 10.3390/pharmaceutics12121182

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  22 in total

1.  In vitro and in vivo inhibitory effects of glycyrrhetinic acid on cytochrome P450 3A activity.

Authors:  Hai Yun Li; Wen Xu; Juan Su; Xi Zhang; Li Wei Hu; Wei Dong Zhang
Journal:  Pharmacology       Date:  2010-10-29       Impact factor: 2.547

Review 2.  Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?

Authors:  William M Lee
Journal:  J Hepatol       Date:  2017-07-20       Impact factor: 25.083

3.  Effects of paeoniflorin on the activities and mRNA expression of rat CYP1A2, CYP2C11 and CYP3A1 enzymes in vivo.

Authors:  Sicong Li; Xuting Li; Dingsheng Yuan; Bin Wang; Rui Yang; Min Zhang; Jinliang Li; Fuqiang Zeng
Journal:  Xenobiotica       Date:  2021-08-02       Impact factor: 1.908

4.  Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export.

Authors:  Ming-Sian Wu; Hung-Rong Yen; Chia-Wen Chang; Tsui-Yi Peng; Chung-Fan Hsieh; Chi-Jene Chen; Tzou-Yien Lin; Jim-Tong Horng
Journal:  J Ethnopharmacol       Date:  2011-01-11       Impact factor: 4.360

5.  Kinetics of acetaminophen absorption and gastric emptying in man.

Authors:  J A Clements; R C Heading; W S Nimmo; L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

6.  In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.

Authors:  Sang-Bum Kim; In-Soo Yoon; Kyu-Sang Kim; Sung-Jun Cho; Yeong Shik Kim; Hyun-Jong Cho; Suk-Jae Chung; Saeho Chong; Dae-Duk Kim
Journal:  Planta Med       Date:  2014-04-07       Impact factor: 3.352

7.  Multiple-dose acetaminophen pharmacokinetics.

Authors:  C G Sahajwalla; J W Ayres
Journal:  J Pharm Sci       Date:  1991-09       Impact factor: 3.534

8.  Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity.

Authors:  Yong Pil Hwang; Chul Yung Choi; Young Chul Chung; Seong Sik Jeon; Hye Gwang Jeong
Journal:  Arch Pharm Res       Date:  2007-10       Impact factor: 4.946

9.  In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.

Authors:  Kai Zhao; Ming Ding; Hui Cao; Zheng-Xin Cao
Journal:  J Pharm Pharmacol       Date:  2012-05-02       Impact factor: 3.765

10.  In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4.

Authors:  Qiao-Li Lv; Gui-Hua Wang; Shu-Hui Chen; Lei Hu; Xue Zhang; Guo Ying; Chong-Zhen Qin; Hong-Hao Zhou
Journal:  Int J Environ Res Public Health       Date:  2015-12-25       Impact factor: 3.390

View more
  1 in total

1.  Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions.

Authors:  Min-Koo Choi; Im-Sook Song
Journal:  Pharmaceutics       Date:  2021-04-23       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.